Cargando…

Bone marrow lesions predict site-specific cartilage defect development and volume loss: a prospective study in older adults

INTRODUCTION: Recent evidence suggests that bone marrow lesions (BMLs) play a pivotal role in knee osteoarthritis (OA). The aims of this study were to determine: 1) whether baseline BML presence and/or severity predict site-specific cartilage defect progression and cartilage volume loss; and 2) whet...

Descripción completa

Detalles Bibliográficos
Autores principales: Dore, Dawn, Martens, Ashleigh, Quinn, Stephen, Ding, Changhai, Winzenberg, Tania, Zhai, Guangju, Pelletier, Jean-Pierre, Martel-Pelletier, Johanne, Abram, François, Cicuttini, Flavia, Jones, Graeme
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2010
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3046535/
https://www.ncbi.nlm.nih.gov/pubmed/21190554
http://dx.doi.org/10.1186/ar3209
_version_ 1782198975252660224
author Dore, Dawn
Martens, Ashleigh
Quinn, Stephen
Ding, Changhai
Winzenberg, Tania
Zhai, Guangju
Pelletier, Jean-Pierre
Martel-Pelletier, Johanne
Abram, François
Cicuttini, Flavia
Jones, Graeme
author_facet Dore, Dawn
Martens, Ashleigh
Quinn, Stephen
Ding, Changhai
Winzenberg, Tania
Zhai, Guangju
Pelletier, Jean-Pierre
Martel-Pelletier, Johanne
Abram, François
Cicuttini, Flavia
Jones, Graeme
author_sort Dore, Dawn
collection PubMed
description INTRODUCTION: Recent evidence suggests that bone marrow lesions (BMLs) play a pivotal role in knee osteoarthritis (OA). The aims of this study were to determine: 1) whether baseline BML presence and/or severity predict site-specific cartilage defect progression and cartilage volume loss; and 2) whether baseline cartilage defects predict site-specific BML progression. METHODS: A total of 405 subjects (mean age 63 years, range 52 to 79) were measured at baseline and approximately 2.7 years later. Magnetic resonance imaging (MRI) of the right knee was performed to measure knee cartilage volume, cartilage defects (0 to 4), and BMLs (0 to 3) at the medial tibial (MT), medial femoral (MF), lateral tibial (LT), and lateral femoral (LF) sites. Logistic regression and generalized estimating equations were used to examine the relationship between BMLs and cartilage defects and cartilage volume loss. RESULTS: At all four sites, baseline BML presence predicted defect progression (odds ratio (OR) 2.4 to 6.4, all P < 0.05), and cartilage volume loss (-0.9 to -2.9% difference per annum, all P < 0.05) at the same site. In multivariable analysis, there was a significant relationship between BML severity and defect progression at all four sites (OR 1.8 to 3.2, all P < 0.05) and BML severity and cartilage volume loss at the MF, LT, and LF sites (β -22.1 to -42.0, all P < 0.05). Additionally, baseline defect severity predicted BML progression at the MT and LF sites (OR 3.3 to 3.7, all P < 0.01). Lastly, there was a greater increase in cartilage volume loss at the MT and LT sites when both larger defects and BMLs were present at baseline (all P < 0.05). CONCLUSIONS: Baseline BMLs predicted site-specific defect progression and cartilage volume loss in a dose-response manner suggesting BMLs may have a local effect on cartilage homeostasis. Baseline defects predicted site-specific BML progression, which may represent increased bone loading adjacent to defects. These results suggest BMLs and defects are interconnected and play key roles in knee cartilage volume loss; thus, both should be considered targets for intervention.
format Text
id pubmed-3046535
institution National Center for Biotechnology Information
language English
publishDate 2010
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-30465352011-03-01 Bone marrow lesions predict site-specific cartilage defect development and volume loss: a prospective study in older adults Dore, Dawn Martens, Ashleigh Quinn, Stephen Ding, Changhai Winzenberg, Tania Zhai, Guangju Pelletier, Jean-Pierre Martel-Pelletier, Johanne Abram, François Cicuttini, Flavia Jones, Graeme Arthritis Res Ther Research Article INTRODUCTION: Recent evidence suggests that bone marrow lesions (BMLs) play a pivotal role in knee osteoarthritis (OA). The aims of this study were to determine: 1) whether baseline BML presence and/or severity predict site-specific cartilage defect progression and cartilage volume loss; and 2) whether baseline cartilage defects predict site-specific BML progression. METHODS: A total of 405 subjects (mean age 63 years, range 52 to 79) were measured at baseline and approximately 2.7 years later. Magnetic resonance imaging (MRI) of the right knee was performed to measure knee cartilage volume, cartilage defects (0 to 4), and BMLs (0 to 3) at the medial tibial (MT), medial femoral (MF), lateral tibial (LT), and lateral femoral (LF) sites. Logistic regression and generalized estimating equations were used to examine the relationship between BMLs and cartilage defects and cartilage volume loss. RESULTS: At all four sites, baseline BML presence predicted defect progression (odds ratio (OR) 2.4 to 6.4, all P < 0.05), and cartilage volume loss (-0.9 to -2.9% difference per annum, all P < 0.05) at the same site. In multivariable analysis, there was a significant relationship between BML severity and defect progression at all four sites (OR 1.8 to 3.2, all P < 0.05) and BML severity and cartilage volume loss at the MF, LT, and LF sites (β -22.1 to -42.0, all P < 0.05). Additionally, baseline defect severity predicted BML progression at the MT and LF sites (OR 3.3 to 3.7, all P < 0.01). Lastly, there was a greater increase in cartilage volume loss at the MT and LT sites when both larger defects and BMLs were present at baseline (all P < 0.05). CONCLUSIONS: Baseline BMLs predicted site-specific defect progression and cartilage volume loss in a dose-response manner suggesting BMLs may have a local effect on cartilage homeostasis. Baseline defects predicted site-specific BML progression, which may represent increased bone loading adjacent to defects. These results suggest BMLs and defects are interconnected and play key roles in knee cartilage volume loss; thus, both should be considered targets for intervention. BioMed Central 2010 2010-12-29 /pmc/articles/PMC3046535/ /pubmed/21190554 http://dx.doi.org/10.1186/ar3209 Text en Copyright ©2010 Dore et al.; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Dore, Dawn
Martens, Ashleigh
Quinn, Stephen
Ding, Changhai
Winzenberg, Tania
Zhai, Guangju
Pelletier, Jean-Pierre
Martel-Pelletier, Johanne
Abram, François
Cicuttini, Flavia
Jones, Graeme
Bone marrow lesions predict site-specific cartilage defect development and volume loss: a prospective study in older adults
title Bone marrow lesions predict site-specific cartilage defect development and volume loss: a prospective study in older adults
title_full Bone marrow lesions predict site-specific cartilage defect development and volume loss: a prospective study in older adults
title_fullStr Bone marrow lesions predict site-specific cartilage defect development and volume loss: a prospective study in older adults
title_full_unstemmed Bone marrow lesions predict site-specific cartilage defect development and volume loss: a prospective study in older adults
title_short Bone marrow lesions predict site-specific cartilage defect development and volume loss: a prospective study in older adults
title_sort bone marrow lesions predict site-specific cartilage defect development and volume loss: a prospective study in older adults
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3046535/
https://www.ncbi.nlm.nih.gov/pubmed/21190554
http://dx.doi.org/10.1186/ar3209
work_keys_str_mv AT doredawn bonemarrowlesionspredictsitespecificcartilagedefectdevelopmentandvolumelossaprospectivestudyinolderadults
AT martensashleigh bonemarrowlesionspredictsitespecificcartilagedefectdevelopmentandvolumelossaprospectivestudyinolderadults
AT quinnstephen bonemarrowlesionspredictsitespecificcartilagedefectdevelopmentandvolumelossaprospectivestudyinolderadults
AT dingchanghai bonemarrowlesionspredictsitespecificcartilagedefectdevelopmentandvolumelossaprospectivestudyinolderadults
AT winzenbergtania bonemarrowlesionspredictsitespecificcartilagedefectdevelopmentandvolumelossaprospectivestudyinolderadults
AT zhaiguangju bonemarrowlesionspredictsitespecificcartilagedefectdevelopmentandvolumelossaprospectivestudyinolderadults
AT pelletierjeanpierre bonemarrowlesionspredictsitespecificcartilagedefectdevelopmentandvolumelossaprospectivestudyinolderadults
AT martelpelletierjohanne bonemarrowlesionspredictsitespecificcartilagedefectdevelopmentandvolumelossaprospectivestudyinolderadults
AT abramfrancois bonemarrowlesionspredictsitespecificcartilagedefectdevelopmentandvolumelossaprospectivestudyinolderadults
AT cicuttiniflavia bonemarrowlesionspredictsitespecificcartilagedefectdevelopmentandvolumelossaprospectivestudyinolderadults
AT jonesgraeme bonemarrowlesionspredictsitespecificcartilagedefectdevelopmentandvolumelossaprospectivestudyinolderadults